These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 6282968

  • 1. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S, Loo LS.
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [Abstract] [Full Text] [Related]

  • 2. Protection of neonatal mice against herpes simplex viral infection by human antibody and leukocytes from adult, but not neonatal humans.
    Kohl S, Loo LS, Pickering LK.
    J Immunol; 1981 Oct; 127(4):1273-5. PubMed ID: 7276559
    [Abstract] [Full Text] [Related]

  • 3. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
    Kohl S, Loo LS, Schmalstieg FS, Anderson DC.
    J Immunol; 1986 Sep 01; 137(5):1688-94. PubMed ID: 3528287
    [Abstract] [Full Text] [Related]

  • 4. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S, Thomas JW, Loo LS.
    J Immunol; 1986 Apr 15; 136(8):3038-44. PubMed ID: 3007609
    [Abstract] [Full Text] [Related]

  • 5. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S, Loo LS, Greenberg SB.
    J Immunol; 1982 Mar 15; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract] [Full Text] [Related]

  • 6. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
    Kohl S.
    J Immunol; 1990 Jan 01; 144(1):307-12. PubMed ID: 2153165
    [Abstract] [Full Text] [Related]

  • 7. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
    Kohl S, Cahall DL, Walters DL, Schaffner VE.
    J Immunol; 1979 Jul 01; 123(1):25-30. PubMed ID: 448149
    [Abstract] [Full Text] [Related]

  • 8. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM, Shore SL, Ades EW, Phillips DJ.
    J Immunol; 1977 Feb 01; 118(2):567-73. PubMed ID: 65428
    [Abstract] [Full Text] [Related]

  • 9. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF, Welsh RM.
    J Immunol; 1986 May 01; 136(9):3481-5. PubMed ID: 2420892
    [Abstract] [Full Text] [Related]

  • 10. Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.
    Kohl S, Starr SE, oleske JM, Shore SL, Ashman RB, Nahmias AJ.
    J Immunol; 1977 Mar 01; 118(3):729-35. PubMed ID: 191525
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR, Rodriguez A, Hoang-Xuan T, Foster CS.
    Ger J Ophthalmol; 1993 Aug 01; 2(4-5):218-23. PubMed ID: 8220102
    [Abstract] [Full Text] [Related]

  • 13. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
    Schrier RD, Ishioka GY, Pizer LI, Moorhead JW.
    J Immunol; 1985 May 01; 134(5):2889-93. PubMed ID: 2580006
    [Abstract] [Full Text] [Related]

  • 14. Human colostral cytotoxicity: I. Antibody-dependent cellular cytotoxicity against Herpes simplex viral-infected cells mediated by colostral cells.
    Kohl S, Malloy MM, Pickering LK, Morriss FH, Adcock EW, Walters DL.
    J Clin Lab Immunol; 1978 Nov 01; 1(3):221-4. PubMed ID: 756470
    [Abstract] [Full Text] [Related]

  • 15. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S.
    Rev Infect Dis; 1991 Nov 01; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [Abstract] [Full Text] [Related]

  • 16. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM, Wolcott RM, Chervenak R, Jennings SR.
    Virology; 1994 Jul 01; 202(1):76-88. PubMed ID: 7912023
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B, Allison AC.
    J Immunol; 1976 Jan 01; 116(1):35-40. PubMed ID: 173758
    [Abstract] [Full Text] [Related]

  • 18. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R, Tauber J, Ihley TM, Opremcak EM, Foster CS.
    Invest Ophthalmol Vis Sci; 1990 Nov 01; 31(11):2335-41. PubMed ID: 2173686
    [Abstract] [Full Text] [Related]

  • 19. Ontogeny of protection of neonatal mice from lethal herpes simplex virus infection by human leukocytes, antiviral antibody, and recombinant alpha-interferon.
    Kohl S, Bigelow RH, Loo LS.
    Pediatr Res; 1984 Nov 01; 18(11):1164-7. PubMed ID: 6514442
    [Abstract] [Full Text] [Related]

  • 20. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA, Knipe DM.
    Virology; 1997 Dec 22; 239(2):315-26. PubMed ID: 9434723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.